(December 13, 2019, 2:42 PM EST) -- WILMINGTON, Del. — A Delaware Superior Court judge on Dec. 10 ruled in a breach of contract and trade secret misappropriation lawsuit that a genomic services company was on inquiry notice that a former customer had allegedly violated the terms of a product access agreement when it continued to use the and access the plaintiff’s intellectual property (IP) more than three years before filing its lawsuit (Ocimum Biosolutions (India) Limited, et al. v. AstraZeneca UK Limited, No. N15C-08-168, Del. Super.)....